Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes by Giha, H.A. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine-year longitudinal study of antibodies to variant antigens on
the surface of Plasmodium falciparum-infected erythrocytes
Citation for published version:
Giha, HA, Staalsoe, T, Dodoo, D, Theander, TG, Hviid, L, Elhassan, IM, Satti, GMH, Roper, C & Arnot, DE
1999, 'Nine-year longitudinal study of antibodies to variant antigens on the surface of Plasmodium
falciparum-infected erythrocytes' Infection and Immunity, vol 67, no. 8, pp. 4092-4098.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Infection and Immunity
Publisher Rights Statement:
RoMEO blue
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
INFECTION AND IMMUNITY,
0019-9567/99/$04.0010
Aug. 1999, p. 4092–4098 Vol. 67, No. 8
Copyright © 1999, American Society for Microbiology. All Rights Reserved.
Nine-Year Longitudinal Study of Antibodies to Variant Antigens on
the Surface of Plasmodium falciparum-Infected Erythrocytes
HAIDER A. GIHA,1,2* TRINE STAALSOE,1 DANIEL DODOO,1,3 IBRAHIM M. ELHASSAN,2 CALLY ROPER,4
GWIRIA M. H. SATTI,2 DAVID E. ARNOT,4 THOR G. THEANDER,1 AND LARS HVIID1
Centre for Medical Parasitology, Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet),
and Institute for Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark1;
Department of Biochemistry and Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan2;
Immunology Unit, Noguchi Memorial Institute for Medical Research, Legon, Ghana3; and
Institute for Cell, Animal, and Population Biology, University of Edinburgh, Edinburgh, Scotland4
Received 9 February 1999/Returned for modification 29 March 1999/Accepted 18 May 1999
PfEMP1 is an antigenically variable molecule which mediates the adhesion of parasitized erythrocytes to a
variety of cell types and which is believed to constitute an important target for naturally acquired protective
immune responses in malaria. For 9 years we have monitored individuals living in an area of low-intensity,
seasonal, and unstable malaria transmission in eastern Sudan, and we have used this database to study the
acquisition, specificity, and duration of the antibody response to variant parasitized erythrocyte surface
antigens. Both the levels and the spectrum of reactivity of these antibodies varied considerably among
individuals, ranging from low levels of antibodies recognizing only few parasitized erythrocyte surface antigens
to high levels of broad-specificity antibodies. In general, episodes of clinical malaria were associated with
increases in the levels of parasitized erythrocyte surface-specific antibodies that subsided within months of the
attack. This response was often, but not always, specific for the antigenic variants expressed by the parasite
isolate causing disease. Our study provides evidence that Palciparum falciparum malaria is associated with a
short-lived, variant-specific antibody response to PfEMP1-like antigens exposed on the surface of parasitized
erythrocytes. Furthermore, our data suggest that the antigenic repertoires of variant antigens expressed by
different parasite isolates show considerable overlapping, at least under Sahelian conditions of low-intensity,
seasonal, and unstable malaria transmission. Finally, we demonstrate the existence of persistent differences
among individuals in the capacity to mount antibody responses to variant surface antigens.
People living in areas of high Plasmodium falciparum ma-
laria endemicity gradually develop substantial clinical protec-
tion against the disease over a period of several years; this is
believed to reflect acquisition of protective immunity. How-
ever, although a variety of immune responses directed against
numerous parasite antigens have been identified, it is still un-
clear which responses, and of what specificities, are essential
for immunity. Recent evidence points to the importance of
antibody responses specific for antigenically variable molecules
expressed on the surface of P. falciparum-infected erythrocytes
(4, 16). One such class of molecules, the PfEMP1 proteins,
encoded by the var multigene family (2, 25, 28), are responsible
of the sequestration of parasitized erythrocytes to the walls of
postcapillary venules and certain other cytoadhesion pheno-
types (14). The ability of infected cells to adhere to endothelial
cells is thought to be central to the pathogenesis of P. falcipa-
rum malaria, and the acquisition of agglutinating antibodies,
which mainly recognize PfEMP1-like molecules, has been
linked to the development of protective immunity (4, 17). In
addition to the ability of PfEMP1 to mediate endothelial se-
questration, it is involved in the formation of rosettes, i.e., the
binding of uninfected erythrocytes to a central parasitized cell
(24, 32). Like sequestration, rosette formation has been impli-
cated in malarial pathogenesis, and levels of antibodies capable
of disrupting such rosettes have been reported to correlate
with protective immunity (5, 6). The present study was under-
taken to investigate the acquisition, specificity, and persis-
tence of antibodies recognizing PfEMP1-like molecules under
conditions of low-intensity, seasonal, and unstable malaria
transmission; these conditions permit the analysis of human
infections without the complicating effect of continuous super-
infection often found in areas of high transmission intensity.
MATERIALS AND METHODS
Study area. The study was carried out between 1988 and 1997 in the village of
Daraweesh, Gedaref State, Sudan, located 430 km southeast of the capital
Khartoum. The region is characterized by a short rainy season from July to
October, whereas the remainder of the year is hot and dry. Essentially all malaria
cases are seen during and shortly after the rainy season, from August to Novem-
ber. Malaria transmission in the region is unstable and is dependent on precip-
itation, which varies considerably between years. An epidemic of malaria fol-
lowed unusually heavy rains in 1988, while very few cases were seen during the
drought of 1990 and 1991. From 1992 to 1996 the annual incidence of malaria in
Daraweesh has varied, with 24.7 to 35.2% of the population suffering at least one
malaria attack (29). The predominant species of malaria parasite is P. falciparum
(98% of cases), with P. vivax and P. malariae occasionally seen. The sole vector
is Anopheles arabiensis.
Study cohort. This study is part of a longitudinal study of infection and
immunity to malaria in Daraweesh which has been under way since 1990. The
study has received ethical approval from the ethical Committee of the University
of Khartoum and national clearance from the Sudanese Ministry of Health. For
the present study, we used data and samples from a cohort of 37 permanent
residents (12 males, 25 females; age range in 1995, 7 to 51 years) monitored
clinically and parasitologically by passive case detection for up to 9 years from
1988 to 1997. During the malaria season, all individuals feeling unwell reported
to a health team that was present in the village on a daily basis. Blood smears
were obtained from all individuals with a body temperature of .37.5°C and/or
other symptoms suggestive of malaria. Individuals with clinical symptoms sug-
gestive of malaria and patent parasitaemia in Giemsa-stained blood films were
classified as having clinical episodes of malaria, and curative treatment was
initiated.
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Blood samples. Venous blood samples were collected in heparinized Vacu-
tainers (Becton Dickinson, Rutherford, N.J.). Following centrifugation, plasma
was collected and stored at 220°C until use. From donors with malaria, the pellet
of infected erythrocytes (IRBC) was collected, washed in RPMI 1640, resus-
pended in 28% glycerol, and snap-frozen in liquid nitrogen as described else-
where (18). Informed consent was always obtained from the donors and/or their
parents prior to the collection of blood samples.
Cultivation and characterization of parasite isolates. Frozen IRBC were
thawed, washed, diluted with fresh uninfected O Rh1 erythrocytes (RBC), and
cultured by a modification (10) of the method originally described by Trager and
Jensen (30). In brief, the isolates were grown in RPMI 1640 medium supple-
mented with 10% Albumax II (Life Technologies, Tåstrup, Denmark), 24 mM
sodium bicarbonate, 2 mM HEPES buffer, and 50 mg of gentamicin (Gibco,
Paisley, United Kingdom) per ml. Cultures were maintained at 37°C in an
atmosphere of 94% nitrogen, 5% carbon dioxide, and 1% oxygen, and the culture
medium was changed every other day. The growth rate was monitored by mi-
croscopic examination of Giemsa-stained smears. For the initial characterization
of parasite isolates and levels of antibodies to PfEMP1-like antigens in plasma
(see below), we used nine P. falciparum isolates obtained this way. Of these, six
were primary isolates from Daraweesh (S9457, Z453, Z455, Z456, Y391, and
Y395), one was a primary isolate from Ghana (L73), and the last two were
long-term laboratory isolates (FCR3 and 3D7). For the detailed longitudinal
analysis, we used four isolates from Daraweesh, collected during the malaria
seasons of 1994 (S9457), 1995 (Z453 and Z455), and 1996 (Y372), respectively.
All isolates were characterized genotypically by PCR analysis of polymorphic
regions of three P. falciparum antigens, PfMSP1, PfMSP2, and GLURP as
described elsewhere (22, 23).
Measurement of levels of Pf EMP1-like antibodies in plasma by flow cytom-
etry. Levels in plasma of antibodies recognizing PfEMP1-like antigens expressed
on the surface of RBC infected by late-stage P. falciparum parasites were mea-
sured by a flow cytometry assay developed by us and described in detail else-
where (26). In brief, in vitro cultures with the majority of the parasites in the late
trophozoite and schizont stages and a parasitemia of 2 to 3% were first labelled
with ethidium bromide (40 mg/ml). Labelled cultures were subsequently enriched
for late-stage parasites by exposure to a high-gradient magnetic field (MACS;
Miltenyi Bio Tec, Bergisch Gladbach, Germany) (19, 26), and parasitemias of 40
to 60% late trophozoites and schizonts were found. Aliquots (100 ml) of late-
stage-enriched IRBC were then sequentially incubated with test plasma (5 ml),
goat anti-human immunoglobulin G (0.2 ml; DAKO, Glostrup, Denmark), and
fluorescein isothiocyanate-conjugated rabbit anti-goat immunoglobulin G
(DAKO). The duration of each incubation was 30 min, and the samples were
extensively washed (in phosphate-buffered saline supplemented with 2% fetal
calf serum) between incubations. All steps were done at room temperature.
Finally, the samples were washed, resuspended in 300 ml of washing medium, and
analyzed on an EPICS XL-MCL flow cytometer (Coulter, Miami, Fla.). IRBC
were identified by their forward- and side-scatter properties and by their
ethidium bromide fluorescence. Levels of PfEMP1-like antibodies in plasma
were then quantified by determining the mean fluorescein isothiocyanate fluo-
rescence of gated IRBC. All analysis of flow cytometric data was done with the
PC Lysys software package (Becton Dickinson). For each parasite isolate tested,
all test plasma samples were run in parallel, together with a pool of plasma
samples obtained from Ghanaian adults living in an area of hyperendemic ma-
laria transmission (positive control) and four individual plasma samples and a
serum pool from nonexposed individuals (negative controls).
RESULTS
Characterization of parasite isolates. All the parasite iso-
lates were genotypically distinct according to analysis of mark-
ers at polymorphic sites of PfMSP1, PfMSP2, and GLURP
(Table 1). In accordance with this, serological typing with
plasma samples obtained after the malaria season of 1995 to
1996 (January 1996) from the 37 members of the Daraweesh
cohort (all healthy at that time point) showed discrete recog-
nition patterns for each isolate (Fig. 1). However, among the
field isolates the isolates Z453 and Z455 were genotypically
identical at all markers except PfMSP2 (Table 1) and the
recognition patterns obtained by serological typing of
PfEMP1-like antigens on the surface of erythrocytes infected
by these two isolates were very similar (Fig. 1). Isolates Z453
and Z455 were collected on the same day from siblings living
in the same hut and developing malaria on the same day. It
seems likely that Z453 and Z455 originated from the same
mosquito that infected both children on the same occasion
with an inoculation in which there was at least one common
clone. A third isolate originating from the same hut and on the
same day (Z456) was distinct from Z453 and Z455 by both
genetic and serological typing (Table 1 and Fig. 1).
Four of the Daraweesh isolates collected in 1994 (S9457),
1995 (Z453 and Z455), and 1996 (Y372) were frequently rec-
ognized by plasma of individuals from Daraweesh (Fig. 1 and
data not shown) and were selected for the detailed longitudinal
analysis of antibodies to PfEMP1-like antigens described be-
low.
Screening of plasma samples for levels of antibodies to
PfEMP1-like antigens. In addition to revealing antigenic dif-
ferences between the parasite isolates used, the serological
typing demonstrated marked variation in the spectrum of an-
tibodies recognizing PfEMP1-like antigens between individual
plasma samples (Fig. 1). At one end of the spectrum was the
sample obtained from donor E2, which showed only borderline
recognition of the two laboratory isolates and no recognition of
any of the primary field isolates (Fig. 1 and data not shown). At
the other end, plasma from donor 2N3 contained high levels of
antibodies to PfEMP1-like antigens expressed by all nine iso-
lates (Fig. 1 and data not shown). We examined the relation-
ship between the number of parasite isolates recognized by
individual plasma samples and several possible explanatory
variables. However, neither donor age [P(r) 5 0.87, Pearson
product moment correlation], number of clinical malaria epi-
sodes during 1993 to 1995 [P(r) 5 0.96] or 1995 only [P(r) 5
0.10], nor number of asymptomatic episodes of parasitemia,
whether detected by Giemsa-stained blood films [P(r) 5 0.2) or
by PCR [P(r) 5 0.17] showed a significant relationship. Asymp-
tomatic parasitemia was detected during cross-sectional sur-
veys in January, April, and June of each year from 1993 to 1995
as described elsewhere (23).
Based on these results (Fig. 1), three individuals, E2, 2P4,
and 2N3, whose plasma samples appeared to contain qualita-
TABLE 1. Characterization of parasite isolates
Isolate Donor Origin, date obtained(day/mo/yr)
Genotype Minimum
no. of
clonesPfMSP1 block 2 PfMSP1 C terminus PfMSP2 GLURP
3D7 Laboratory isolate MAD20 MAD20 3D7 E 1
FCR3 Laboratory isolate MAD20 Wellcome, K1 3D7 D 2
L73 Dodowa, Ghana, 30/11/94 MAD20 Wellcome, MAD20 FC27, 3D7 F 2
Y391 G12 Daraweesh, 08/11/96 K1 Wellcome, K1 FC27 F 2
Y395 2D3 Daraweesh, 11/11/96 K1 Wellcome, K1 FC27 C 2
S9457 2Q4 Daraweesh, 12/10/94 RO33, MAD20, K1 MAD20, FC27 3D7 F 3
Y372 X5 Daraweesh, 26/10/96 MAD20 MAD20, FC27 3D7 E 2
Z453 P11 Daraweesh, 30/10/95 RO33 MAD20, FC27 FC27 B 2
Z455 P8 Daraweesh, 30/10/95 RO33 MAD20, FC27 3D7 B 2
Z456 P5 Daraweesh, 30/10/95 RO33 Wellcome, K1 3D7 B 2
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tively and quantitatively limited, intermediate, and high anti-
body recognition of PfEMP1-like antigens, respectively, were
selected for more detailed longitudinal analysis.
Malaria-induced changes in levels of antibodies to
PfEMP1-like antigens. Individual E2 was a female aged 18
years at the time of the collection of the first blood sample
(1988). A total of 16 plasma samples collected between June
1988 and March 1997 from this donor were analyzed for the
presence of antibodies to parasitized RBC surface antigens
expressed by four parasite isolates obtained at various time
points from Daraweesh. In line with the data obtained with the
nine isolates (Fig. 1), only very limited recognition of any of the
isolates was seen at any time point with plasma samples from
this donor, including plasma samples donated by this individ-
ual after each of two monitored malaria episodes (Fig. 2, left
column).
A total of 10 plasma samples from individual 2P4, a male
aged 8 years at the time of the collection of the first sample,
were analyzed. During the period between collection of the
first (September 1991) and last (March 1997) plasma samples,
he experienced two clinical malaria episodes, both of which
were associated with increases in titers of antibodies specific
for PfEMP1-like antigens expressed on the surface of IRBC
infected with any of the four isolates tested (Fig. 2, center
column).
Individual 2N3 was a male aged 5 years at the time of
collection of the first of 14 samples between November 1989
and March 1997. He suffered four malaria attacks between
1993 and 1995, but unfortunately no plasma samples were
obtained at the times of the clinical attacks in November 1994
and January 1995. However, in the other two malaria episodes
(November 1993 and October 1995), where plasma samples
were available, these were both associated with marked in-
creases in recognition of PfEMP1-like molecules expressed by
each of the test isolates (Fig. 2, right column).
Isolate specificity of antibodies to PfEMP1-like antigens.
The availability of a series of plasma samples obtained at
various time points before and after collection of a parasite
isolate from the same individual offered a unique opportunity
to investigate the specificity of antibodies recognizing variant
IRBC antigens. Nine plasma samples were collected between
June 1995 and March 1997 from individual P8, a female aged
8 years at the time of the collection of the first plasma sample.
The two plasma samples obtained from this individual before
a malaria episode in October 1995 (caused by isolate Z455)
were unable to recognize any of the test isolates (including
Z455) (Fig. 3, left column). While limited disease-induced
increases in the responses to the heterologous isolates S9457
and Y372 were observed, the recognition of RBC infected by
Z455 parasites increased considerably following the malaria
episode caused by this isolate. Thus, the malaria attack known
to have been caused by Z455 resulted in the development of
antibodies specifically recognizing antigens on the surface of
RBCs infected by this isolate but not by the unrelated isolates
S9457 and Y372. In addition, the Z455-induced malaria epi-
sode caused an increase in the antibody reactivity to isolate
Z453, slightly lower in magnitude but closely paralleling the
response to Z455. As mentioned above, siblings P8 and P11
had malaria diagnosed on the same day, at which time Z455
was isolated from P8 and Z453 was isolated from P11.
In line with the above findings, the Z453-induced malaria
episode in individual P11 (male, aged 4 years at the time of first
sampling) was associated with markedly increased recognition
of PfEMP1-like molecules expressed by this isolate, with little
effect on the recognition of isolates S9457 and Y372 (Fig. 3,
right panel). As with P8, recognition by antibodies in the
plasma of P11 of the parasite isolate obtained from the sibling
(Z455) was lower but otherwise strikingly similar to that of the
autologous isolate, Z453 (Fig. 3, right panel).
Although these findings strongly suggest a close relationship
between isolates Z453 and Z455, they were not identical, since
recognition of the autologous isolate by antibodies in plasma of
both P8 and P11 was stronger than that of the isolate obtained
from the sibling (Fig. 3). The Z453 and Z455 isolates had
different alleles of the PfMSP2 gene as well as showing differ-
ent variants of the 39 end of the PfMSP1 gene. The simplest
explanation of the relationship between these isolates, each of
which contains at least two clones, is that they contained a
clone in common.
FIG. 1. Levels of plasma antibodies recognizing PfEMP1-like molecules on
the surface of intact RBC infected with late developmental stages of P. falcipa-
rum as detected by flow cytometry. Data from nine parasite isolates (3D7 to
FCR3 [columns]) tested versus plasma samples obtained in January 1996 from 37
individuals (E2 to 2N3 [rows]) from Daraweesh village, Sudan, are shown. Shad-
ing indicates antibody levels above background (mean 1 2 standard deviations of
samples from unexposed individuals). Numbers along the right and bottom edges
of the figure indicate the number of positive data points per plasma sample and
parasite isolate, respectively.
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DISCUSSION
PfEMP1 is a variant molecule expressed on the surface of
RBC infected with late developmental stages (mature tropho-
zoites and schizonts) of P. falciparum parasites (31). PfEMP1 is
encoded by the large var gene family (2, 25, 28), is the main
molecule mediating the sequestration of IRBC to a variety of
host receptors, and as such is believed to be a major factor in
the pathogenesis of P. falciparum malaria (1, 20). Clonal vari-
ation in the expression of PfEMP1 can occur at around 2% per
generation (21). The presence or absence of antibodies to
particular PfEMP1 variants appears closely associated with
susceptibility to infection with a particular P. falciparum isolate
(4), and accumulation of a comprehensive repertoire of anti-
FIG. 2. Long-term changes in levels of plasma antibodies recognizing PfEMP1-like molecules on the surface of intact RBC infected with late developmental stages
of P. falciparum as detected by flow cytometry. The reactivity of plasma from three individuals selected for low (E2, left column), medium (2P4, center column), and
high (2N3, right column) antibody levels with four parasite isolates collected in 1994 (S9457, top row), 1995 (Z453, second row; Z455, third row), and 1996 (Y372,
bottom row) are shown. The x axis shows the date. The y axis shows the anti-PfEMP1-like antibody reactivity (mean flow cytometer channel number). The negative
cutoff (mean 1 2 standard deviations for five plasma samples from unexposed individuals) is shown as a dotted horizontal line. The level of anti-PfEMP1-like antibodies
in a pool of hyperimmune plasma (positive control) is shown as a dashed horizontal line. Solid vertical lines indicate clinical episodes of malaria.
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bodies recognizing antigenically distinct PfEMP1 molecules
may be the key to acquisition of clinical protection.
Studies of acquisition, decay, and specificity of anti-PfEMP1
antibodies in areas of intense parasite transmission are made
difficult by the regular infectious challenge of individuals living
in these areas and the consequent age-specific buildup of pro-
tective immunity. We have addressed these questions in a
longitudinal study of individuals in a Sudanese village situated
in an area of low-intensity, seasonal malaria transmission,
where there are much less marked age-dependent differences
in susceptibility to clinical disease and where individuals are
exposed to only a few new infections per year. We have used
plasma samples collected over periods of up to 9 years from
permanent residents of this village to measure their capacity to
recognize variant PfEMP1-like antigens expressed by RBC
infected by a panel of different P. falciparum isolates. To per-
mit such a study, which necessitates the analysis of a large array
of plasma and parasite isolates, we have developed a flow
FIG. 3. Long-term changes in levels of plasma antibodies recognizing PfEMP1-like molecules on the surface of intact RBC infected with late developmental stages
of homologous and heterologous P. falciparum isolates as detected by flow cytometry. The reactivity of plasma from two individuals (P8 [left column] and P11 [right
column]) with four parasite isolates collected in 1994 (S9457, top row), 1995 (Z453, second row; Z455, third row), and 1996 (Y372, bottom row) is shown. Isolates Z455
and Z453 were collected during clinical malaria attacks in November 1995 from individuals P8 and P11, respectively. Symbols are as in Fig. 2.
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cytometric assay that allows convenient and unbiased analysis
of many samples (26). The assay detects antibodies on the
surface of intact RBC infected with mature P. falciparum par-
asites, and the antigens recognized by these antibodies vary
between isolates and have the molecular weight and properties
expected of PfEMP1. However, we cannot formally rule out a
contribution from antibodies recognizing other variant anti-
gens, such as the rosettins and/or the STEVOR and RIF pro-
teins (8, 13). Our flow cytometric assay correlates well with
conventional assays for detection of agglutinating antibodies
(12).
Our data show a marked interindividual variation in levels
and specificities of antibodies recognizing PfEMP1-like anti-
gens in this area of low-intensity malaria transmission. Neither
the age of the plasma donors nor the number of previous
episodes of clinical disease or asymptomatic parasitemia cor-
related significantly with the number of isolates recognized.
Antibodies from plasma of some individuals, such as E2,
showed only borderline recognition of few parasite isolates.
Several mutually nonexclusive factors may contribute to this
nonresponsiveness. Samples from E2 have generally shown
minimal levels of antibody to other malaria antigen prepara-
tions, including PfMSP1 (7), RAP-1 (11), and crude schizont
extract (12a), even in samples obtained shortly after docu-
mented clinical attacks. This result and the lack of recognition
in E2 of PfEMP1-like antigens expressed by any of nine par-
asite isolates (Fig. 1) suggest that genetic factors are involved
in determining host responsiveness. The limited antibody re-
sponse in E2 to variant antigens expressed by any of four
isolates at the time of the two malaria episodes in this individ-
ual supports this conclusion (Fig. 2, left column). Alternatively,
it may reflect antigenic differences between the parasites caus-
ing these episodes and those present in the test isolates. How-
ever, both the present study (e.g., the broadly reactive antibody
response following infection in 2N3 [Fig. 2, right column]) and
our previous findings from the same village (12) suggest that
the repertoires of variant antigens on the surface of RBC
infected with parasite isolates present in our study area overlap
considerably. This hypothesis is supported by the fact that
although the four isolates used in the longitudinal study (Fig. 2
and 3) were obtained between 1994 and 1996 (Table 1), several
plasma samples collected before the time of their isolation
contained antibodies to variant antigens expressed by each of
them (Fig. 2). Furthermore, the two malaria attacks occurring
in individual 2P4 during the study period both produced an
increase in levels of plasma antibodies recognizing all four
parasite isolates tested (Fig. 2, center column). This finding
clearly implies that the parasites causing these two disease
episodes and those present in the test isolates were antigeni-
cally related. Similar data were obtained with plasma from
individual 2N3 with respect to the two episodes, where plasma
samples obtained within a few months of the attack were avail-
able (Fig. 2, right column). We found no evidence of disease-
induced increases in antibodies to PfEMP1-like antigens in this
donor in relation to two other, closely spaced malaria attacks
by the turn of the year 1994. However, the next sample was
obtained almost a year later, by which time the antibody levels
may have decreased considerably. Several lines of evidence
support the hypothesis of a relatively short half-life of such
antibodies. First, none of the three individuals from whom
samples obtained before 1992 were available showed any re-
activity before this time. This probably indicates that antibod-
ies recognizing PfEMP1-like antigens in these individuals were
largely lost during the drought years of 1990 and 1991, when
malaria was essentially absent from Daraweesh village. Sec-
ond, the cases where several plasma samples were available
within a limited period following malaria episodes all showed
considerable reduction in antibody levels within a few months.
We have previously speculated that short-lived variant-spe-
cific antibodies may be involved in long-term maintenance of
low-grade asymptomatic infections (27), whereas clinical dis-
ease may be the consequence of acquisition of new, antigeni-
cally different parasites displaying PfEMP1 variants to which
insufficient specific antibodies are present (4, 9, 15). Indeed,
our data on the antibody responses to homologous and heter-
ologous parasites in the siblings P8 and P11 (Fig. 3) strongly
support this hypothesis.
In conclusion, our study provides evidence that clinical dis-
ease episodes cause a marked and variant-specific antibody
response, which usually subsides within months. The data also
clearly suggest that the repertoires of variant antigens ex-
pressed by different isolates overlap to a considerable degree,
in line with our own previous findings (12) as well as with data
from a recent study in Kenya (3). Finally, the capacity to mount
antibody responses to variant surface antigens varies consider-
ably among individuals, possibly reflecting inherent, genetically
restricted differences.
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